Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%

Reuters

07-14

Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%

Hao Tian Management (Hong Kong) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2551507182"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551507182\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2551507182?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-14 22:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551507182","market":"nz","top_or_hot":-1,"title":"Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hao Tian Management (<a href=\"https://laohu8.com/S/HKRHF\">Hong Kong</a>) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-14 22:19</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hao Tian Management (<a href=\"https://laohu8.com/S/HKRHF\">Hong Kong</a>) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1188","symbol_name":"消費信貸","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL8S0Xqc:1","article_id":"2551507182","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551507182","pubTimestamp":1752502740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Hao Tian Management  Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate an","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1188":"消费信贷","01341":"昊天国际建投","00474":"信铭生命科技"},"translate_title":"昊天管理层面临强制售股减持HTICI股份至10.27%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00474":0.9,"01341":0.9},"content_text":"Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n    \n\n        Hao Tian Management (Hong Kong) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}